Log in to save to my catalogue

Selective Effects of Methylphenidate on Attention and Inhibition in 22q11.2 Deletion Syndrome: Resul...

Selective Effects of Methylphenidate on Attention and Inhibition in 22q11.2 Deletion Syndrome: Resul...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8929751

Selective Effects of Methylphenidate on Attention and Inhibition in 22q11.2 Deletion Syndrome: Results From a Clinical Trial

About this item

Full title

Selective Effects of Methylphenidate on Attention and Inhibition in 22q11.2 Deletion Syndrome: Results From a Clinical Trial

Publisher

US: Oxford University Press

Journal title

The international journal of neuropsychopharmacology, 2022-03, Vol.25 (3), p.215-225

Language

English

Formats

Publication information

Publisher

US: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Background
Attention deficit and/or hyperactivity disorder (ADHD) is the most prevalent psychiatric disorder in children with 22q11.2 deletion syndrome (22q11DS) and frequently persists into adulthood. Although medication with stimulant has been demonstrated to be highly effective in idiopathic ADHD, evidence in 22q11DS is still scar...

Alternative Titles

Full title

Selective Effects of Methylphenidate on Attention and Inhibition in 22q11.2 Deletion Syndrome: Results From a Clinical Trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8929751

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8929751

Other Identifiers

ISSN

1461-1457

E-ISSN

1469-5111

DOI

10.1093/ijnp/pyab057

How to access this item